MyFinsight
Home
About
Contact
Back
Income Statement
Apellis Pharmaceuticals, Inc. (APLS)
source: myfinsight.com
Download
Download image
Foreign currency
translation
$485K
Comprehensive loss, net of tax
-$41,666K
Total other
comprehensive income
$485K
Net loss
-$42,151K
Net loss before
taxes
-$41,685K
Income tax expense
$466K
Interest income
$2,607K
Other
income/(expense), net
$146K
Licensing And Other
Revenue
$7,107K
Product
$171,387K
Interest expense
$11,152K
Net operating loss
-$33,286K
Revenue
$178,494K
Total operating
expenses
$211,780K
Cost of sales
$13,626K
Research and development
$67,015K
Selling, general and
administrative
$131,139K
Back